HS Icon Insulin, in dosage

300431 (Harmonized System 1992 for 6-digit)

Overview:  This page contains the latest trade data of Insulin, in dosage. In 2019, Insulin, in dosage were the world's 301st most traded product, with a total trade of $10.2B. Between 2018 and 2019 the exports of Insulin, in dosage grew by 0.56%, from $10.1B to $10.2B. Trade in Insulin, in dosage represent 0.056% of total world trade.

Exports: In 2019 the top exporters of Insulin, in dosage  were Germany ($2.96B), Denmark ($2.49B), France ($2.15B), Italy ($787M), and China ($373M).

Imports: In 2019 the top importers of Insulin, in dosage were United States ($2.11B), France ($972M), Germany ($821M), Denmark ($561M), and United Kingdom ($553M).

Tariffs: In 2018 the average tariff for Insulin, in dosage was 3.44%, making it the 5441st lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Insulin, in dosage are Iran (34.5%), Nepal (15%), Brazil (13.4%), and Argentina (13.4%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking: Insulin, in dosage ranks 1576th in the Product Complexity Index (PCI).

Description: Insulin is a hormone that is important in the regulation of carbohydrate, fat, and protein metabolism. It is used to treat diabetic patients who have either type 1 or type 2 diabetes, and it is also used to treat the symptoms of diabetes in type 2 patients. It is taken by injection and is used to help glucose enter cells, thus lowering the blood glucose levels.

Historical Data

#permalink to section

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2019): Germany, $2.96B

Top Destination (2019): United States, $2.11B

Insulin, in dosage are the world's 301st most traded product.

In 2019, the top exporters of Insulin, in dosage were Germany ($2.96B), Denmark ($2.49B), France ($2.15B), Italy ($787M), and China ($373M).

In 2019, the top importers of Insulin, in dosage were United States ($2.11B), France ($972M), Germany ($821M), Denmark ($561M), and United Kingdom ($553M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2018 -  2019): Greece, $299M

Top Destination Growth (2018 - 2019): France, $289M

Between 2018 and 2019, the exports of Insulin, in dosage grew the fastest in Greece ($299M), Ireland ($56M), United States ($45.4M), Denmark ($45.1M), and China ($40M).

Between 2018 and 2019, the fastest growing importers of Insulin, in dosage were France ($289M), Germany ($102M), Denmark ($79.8M), Saudi Arabia ($45.6M), and United Kingdom ($35.9M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Insulin, in dosage.

In 2019,  market concentration measured using Shannon Entropy, was 2.85. This means that most of the exports of Insulin, in dosage are explained by 7 countries.

Explore Visualizations

TOP NET EXPORTER (2019): Germany, $2.14B

TOP NET IMPORTER (2019): United States, $1.86B

This map shows which countries export or import more of Insulin, in dosage. Each country is colored based on the difference in exports and imports of Insulin, in dosage during 2019.

In 2019, the countries that had a largest trade value in exports than in imports of Insulin, in dosage were Germany ($2.14B), Denmark ($1.93B), France ($1.17B), Italy ($636M), and Greece ($243M).

In 2019, the countries that had a largest trade value in imports than in exports of Insulin, in dosage were United States ($1.86B), United Kingdom ($518M), Spain ($331M), Japan ($283M), and Canada ($262M).

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Insulin, in dosage was 3.44%. The countries with the highest tariffs for importing Insulin, in dosage were Iran (34.5%), Nepal (15%), Brazil (13.4%), and Argentina (13.4%).

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.